Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/21/2003WO2003068967A2 Novel retina specific human proteins wdr17, net01, protein kinase a203, protein kinase mak a194, protein a105, protein a106 and c12orf3variants
08/21/2003WO2003068966A2 REGULATION OF HUMAN Ca2+-PERMEABLE NONSELECTIVE CATION CHANNEL
08/21/2003WO2003068961A2 Method to modify differentiation of pluripotential stem cells
08/21/2003WO2003068959A1 Novel screening method
08/21/2003WO2003068950A1 Tissue-type plasminogen activator (t-pa) inhibitors with a therapeutic capacity
08/21/2003WO2003068949A1 Treatment of muscle damage
08/21/2003WO2003068944A2 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α-
08/21/2003WO2003068943A2 Secreted proteins
08/21/2003WO2003068942A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
08/21/2003WO2003068941A2 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003WO2003068940A2 Complexes and methods of using same
08/21/2003WO2003068939A2 Cks1 INHIBITORS
08/21/2003WO2003068936A2 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
08/21/2003WO2003068934A2 Chimeric molecules for cleavage in a treated host
08/21/2003WO2003068930A2 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
08/21/2003WO2003068922A2 Compositions and methods for treatment of osteoarthritis
08/21/2003WO2003068921A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/21/2003WO2003068912A2 PSEUDOMONAS SYRINGAE HARPINS, HopPtoP AND HopPmaHPTO, AND THEIR USES
08/21/2003WO2003068822A2 De-immunized (poly)peptide constructs
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003068817A1 Management of mucosal viscosity by tff monomer peptides
08/21/2003WO2003068815A2 Mhc class ii peptide epitope of 5t4 antigen
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068810A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
08/21/2003WO2003068808A1 Novel protein complexes and uses therefor
08/21/2003WO2003068807A2 Echinocandin cyclic peptide derivatives
08/21/2003WO2003068805A2 Formulation strategies in stabilizing peptides in organic solvents and in dried states
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068802A2 Materials and methods for preparing dimeric growth factors
08/21/2003WO2003068799A2 Oligomeric molecules and uses thereof
08/21/2003WO2003068287A1 Compositions comprising undifferentiated fetal cells for the treatment of skin disorders
08/21/2003WO2003068270A1 Method of radio-labelling biomolecules
08/21/2003WO2003068261A2 Means and methods for altering the motility of the gastrointestinal tract
08/21/2003WO2003068256A1 Amylase feed supplements for improved ruminant nutrition
08/21/2003WO2003068255A1 Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases
08/21/2003WO2003068254A1 Glycosaminoglycan-dnase combination therapy
08/21/2003WO2003068253A1 Methods and compositions for the treatment of eye diseases
08/21/2003WO2003068224A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003WO2003068188A1 Combination therapy for respiratory disorders
08/21/2003WO2003068187A1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
08/21/2003WO2003068186A1 Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
08/21/2003WO2003068184A1 Use of low molecular protein hydrolysates as anti-inflammable active substances
08/21/2003WO2003068171A2 Method and composition for treatment of inflammation and aids-associated neurological disorders
08/21/2003WO2003068170A2 Enzyme treatment of foodstuffs for celiac sprue
08/21/2003WO2003068168A2 Helical peptidomimetics and use b-amyloid-associated diseases
08/21/2003WO2003068167A2 Novel treatment for pathologies associated with oxidative damage
08/21/2003WO2003068165A2 Angiopoietin-1 in the treatment of disease
08/21/2003WO2003068160A2 Use of insulin-like growth factor binding protein 3 (igf-bp3) for inhibition of tumor growth
08/21/2003WO2003068156A2 Methods for treating or inhibiting sick building syndrome, post-lyme disease syndrome, and/or chronic fatigue syndrome
08/21/2003WO2003068155A2 Inhibition of vegf receptor signaling reverses tumor resistance to radiotherapy
08/21/2003WO2003068150A2 Methods of treating and diagnosing arthritis
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003059385A3 Hiv vaccine and method of use
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003048352A3 Histone h3 methyltransferase polypeptide
08/21/2003WO2003044056A3 Chemically-modified human growth hormone conjugates
08/21/2003WO2003037254A3 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
08/21/2003WO2003025144A3 Antisense modulation of ksr expression
08/21/2003WO2003024474A3 Anti-inflammatory agent
08/21/2003WO2003024471A3 Effect of growth hormone and igf-1 on neural stem cells and therapeutic application
08/21/2003WO2003024404A3 Chemokines as adjuvants of immune response
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003018620A3 Serine protease inhibitor and processes for the preparation thereof
08/21/2003WO2003018052A8 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
08/21/2003WO2003015708A8 Composition and method for treating hiv infection
08/21/2003WO2003006070A3 Improved chelator conjugates
08/21/2003WO2002098459A3 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
08/21/2003WO2002095030A3 Modulation of cd200 receptors
08/21/2003WO2002092620A3 Peptides and related molecules that bind to tall-1
08/21/2003WO2002089779A3 Combined preparation for the prophylaxis and/or therapy of nerve cell and/or glia cell damage using a novel method of treatment
08/21/2003WO2002089739A3 Peptide deformylase activated prodrugs
08/21/2003WO2002088664A3 Control of compactability through crystallization
08/21/2003WO2002085311A3 Hcg formulation
08/21/2003WO2002083182A3 The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification
08/21/2003WO2002082075A3 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
08/21/2003WO2002081692A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003WO2002079398A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/21/2003WO2002077236A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002077198A8 Methods of modulating angiogenesis
08/21/2003WO2002074810A3 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
08/21/2003WO2002068650A3 Modified and stabilized gdf propeptides and uses thereof
08/21/2003WO2002066045A3 Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a
08/21/2003WO2002064776A3 Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002062844A3 Long lasting growth hormone releasing factor derivatives
08/21/2003WO2002060467A3 Compositions and methods for improving kidney function
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002055554A3 Antimicrobial peptides and derived metapeptides
08/21/2003WO2002053174A3 Controlled release pharmaceutical systems
08/21/2003WO2002050545A3 Compositions and methods involving staphylococcus aureus protein staau-r9
08/21/2003WO2002050246A3 Treatment of bone disorders by modulation of fgfr3
08/21/2003WO2002048405A3 Non-invasive method for detecting target rna
08/21/2003WO2002047613A3 Immunogenic cancer peptides and uses thereof
08/21/2003WO2002046449A3 Selection of catalytic nucleic acids targeted to infectious agents
08/21/2003WO2002044324A3 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
08/21/2003WO2002043773A3 Tissue specific prodrugs
1 ... 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 ... 3163